Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shweta Hakre

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Future Oncology (London, England)|February 26, 2025
Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN studyJeff P Sharman, Shweta Hakre
Future Oncology (London, England)|June 9, 2025
How well does acalabrutinib work and how safe is it to treat patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have had previous treatments? a plain language summary of 2 key studiesJohn C Byrd, Shweta Hakre, Paolo Ghia
Current Opinion in HIV and AIDS|January 19, 2011
Epigenetic regulation of HIV latencyShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
FEMS Microbiology Reviews|March 1, 2012
HIV latency: experimental systems and molecular modelsShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
Trends in Microbiology|March 23, 2013
Reactivation of latent HIV by histone deacetylase inhibitorsKotaro Shirakawa, Leonard Chavez, Shweta Hakre, et al.
The Journal of Biological Chemistry|August 24, 2002
The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta /Siz2 is a transcriptional cofactor for TFII-IMaria Isabel Tussie-Luna, Bertha Michel, Shweta Hakre, et al.
Plos Biology|December 6, 2011
Repressive LTR nucleosome positioning by the BAF complex is required for HIV latencyHaleh Rafati, Maribel Parra, Shweta Hakre, et al.
Plos Biology|November 17, 2015
Correction: Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV LatencyHaleh Rafati, Maribel Parra, Shweta Hakre, et al.
Antiviral Chemistry & Chemotherapy|December 10, 2013
Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitorsMary E Manson McManamy, Shweta Hakre, Eric M Verdin, et al.
Molecular Cell|January 5, 2005
An FF domain-dependent protein interaction mediates a signaling pathway for growth factor-induced gene expressionWei Jiang, Raffaella Sordella, Guang-Chao Chen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|February 26, 2025
Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN studyJeff P Sharman, Shweta Hakre
Future Oncology (London, England)|June 9, 2025
How well does acalabrutinib work and how safe is it to treat patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have had previous treatments? a plain language summary of 2 key studiesJohn C Byrd, Shweta Hakre, Paolo Ghia
Current Opinion in HIV and AIDS|January 19, 2011
Epigenetic regulation of HIV latencyShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
FEMS Microbiology Reviews|March 1, 2012
HIV latency: experimental systems and molecular modelsShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
Trends in Microbiology|March 23, 2013
Reactivation of latent HIV by histone deacetylase inhibitorsKotaro Shirakawa, Leonard Chavez, Shweta Hakre, et al.
The Journal of Biological Chemistry|August 24, 2002
The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta /Siz2 is a transcriptional cofactor for TFII-IMaria Isabel Tussie-Luna, Bertha Michel, Shweta Hakre, et al.
Plos Biology|December 6, 2011
Repressive LTR nucleosome positioning by the BAF complex is required for HIV latencyHaleh Rafati, Maribel Parra, Shweta Hakre, et al.
Plos Biology|November 17, 2015
Correction: Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV LatencyHaleh Rafati, Maribel Parra, Shweta Hakre, et al.
Antiviral Chemistry & Chemotherapy|December 10, 2013
Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitorsMary E Manson McManamy, Shweta Hakre, Eric M Verdin, et al.
Molecular Cell|January 5, 2005
An FF domain-dependent protein interaction mediates a signaling pathway for growth factor-induced gene expressionWei Jiang, Raffaella Sordella, Guang-Chao Chen, et al.
Pageof 2